Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors.
Zang L, Kondengaden SM, Zhang Q, Li X, Sigalapalli DK, Kondengadan SM, Huang K, Li KK, Li S, Xiao Z, Wen L, Zhu H, Babu BN, Wang L, Che F, Wang PG.
Zang L, et al. Among authors: wang l, wang pg.
Oncotarget. 2017 Jun 28;8(38):63187-63207. doi: 10.18632/oncotarget.18730. eCollection 2017 Sep 8.
Oncotarget. 2017.
PMID: 28968981
Free PMC article.